Rocket Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Rocket Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Rocket Pharmaceuticals Inc
Rating: 0.90691675
Author: Trendlyne DVM scores

about

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for...

2.96 -0.20 (-6.33%)

89.03% Fall from 52W High

1.7M

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

13.2 / 100

Technically Bearish

23.1 / 100

No estimates available

Rocket Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Rocket Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for...

89.03% Fall from 52W High

SWOT Analysis

Rocket Pharmaceuticals Inc Live Price Chart